This seminar, the third in a series on AI in bioinformatics, features two speakers discussing the role of artificial intelligence and machine learning in immunogenomics and proteomics.
Dr. Iana Safonova from Penn State University addresses the challenges in immunogenomics, focusing on the immense diversity of the adaptive immune system. She explains that processes like VDJ recombination and somatic hypermutation create highly unique antibody and T-cell repertoires, making it difficult to compare immune responses across individuals and species. Dr. Safonova highlights that the underlying genomic loci are themselves hotspots of rapid evolution, characterized by complex structural variations and tandem repeats. She identifies key areas where AI can contribute, including creating better feature representations for this diversity, uncovering patterns in genomic evolution, and aiding in antibody drug design.
Dr. Pavel Sinitcyn from Utrecht University provides an overview of AI's application in mass spectrometry-based proteomics. He details how machine learning is already integral for improving core data analysis tasks, such as enhancing peptide identification through fragment intensity prediction and controlling false discovery rates. He then outlines current and future challenges where advanced AI can play a significant role, including predicting experimental biases, enabling end-to-end de novo sequencing with transformer models, developing PTM-aware protein structure predictions, and tackling the grand challenge of sequencing entire antibody repertoires directly from blood samples.
AI's Role in Immunogenomics and Proteomics
00:00:05 Seminar Introduction: The meeting focuses on the application of state-of-the-art AI and deep learning in bioinformatics, with this session dedicated to immunogenomics and proteomics.
00:03:51 The Challenge of Adaptive Immunity: Dr. Iana Safonova explains that while innate immunity is comparable across individuals, adaptive immunity (B-cells/antibodies and T-cells) is extraordinarily diverse due to somatic V(D)J recombination and hypermutation, making comparisons a major challenge.
00:10:14 Difficulty in Cross-Species Comparison: The genetic basis for antibodies (immunoglobulin loci) evolves so rapidly that it is difficult to find direct one-to-one gene equivalents (orthologs) even between closely related species like humans and other primates, complicating translational studies from model organisms.
00:16:15 Genomic Instability Drives Diversity: Analysis shows that these immune gene regions are highly unstable and prone to rapid evolution through extensive structural variations, such as tandem repeat expansions and contractions, which occur independently in different species.
00:25:27 Key Directions for AI in Immunogenomics: Dr. Safonova outlines several promising areas for AI, including: 1) creating better feature representations to compare diverse antibody repertoires, 2) finding hidden patterns in complex genomic structural variations, 3) determining antibody specificity, and 4) improving antibody drug design.
00:43:06 AI in Proteomics: Dr. Pavel Sinitcyn begins his talk on the role of machine learning in mass spectrometry (MS)-based proteomics.
00:50:54 Shotgun Proteomics Workflow: The standard method involves digesting proteins into smaller peptides, separating them with liquid chromatography, and analyzing them with a mass spectrometer to determine their sequence via fragmentation (MS/MS spectra).
00:58:49 Current ML Applications in MS Data Analysis: Machine learning is already a standard tool for improving MS analysis by predicting peptide properties like chromatography retention time, helping separate true from false identifications (target-decoy), and, most importantly, predicting the intensity of fragment ions to improve database search accuracy.
01:06:49 Future Challenges for AI in MS: Hot topics for research include predicting experimental biases (digestion, solubility), creating end-to-end de novo sequencing models using transformer architectures, and developing "spectra foundation models" for better raw data interpretation.
01:12:21 Application in Personalized Medicine: A key application is in immunopeptidomics, where MS and ML are used to predict which tumor-specific mutations (neoantigens) are presented on a cell's surface, forming the basis for personalized cancer vaccines.
01:16:16 Grand Challenge: Antibody Repertoire Sequencing: A major goal for the field is to use MS and advanced AI to perform large-scale, direct sequencing of the entire antibody repertoire from a blood sample, which could revolutionize immunology and vaccine development.
01:20:28 PTM-Aware Structure Prediction: A significant finding is that post-translational modifications like phosphorylation predominantly occur in structurally disordered regions of proteins. This presents a "chicken-and-egg" problem and a key challenge for AI models aiming to predict protein structure and function in a PTM-aware manner.
01:21:48 A Cautious and Practical Philosophy: Dr. Sinitcyn concludes with advice for applying AI: start with the simplest statistical models first, be mindful of computational resource limitations (GPUs), prioritize model interpretability over black-box approaches, and be vigilant against data leakage.